1-cyclopropyloxy-4,5-difluoro-2-propan-2-ylbenzene;5-fluoro-3-methoxy-2-propan-2-ylpyridine;1-methyl-3-propan-2-yl-1,6-naphthyridin-2-one;6-methyl-3-propan-2-yl-4-(trifluoromethyl)pyridazine;4-methyl-2-propan-2-yl-3-(trifluoromethyl)pyridine;4-propan-2-yl-1,3-benzothiazole;3-propan-2-yl-4-(trifluoromethyl)isoquinoline;2-propan-2-yl-3-(trifluoromethyl)pyrazine
C83H95F15N10O3S — CID 158895492
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-cyclopropyloxy-4,5-difluoro-2-propan-2-ylbenzene;5-fluoro-3-methoxy-2-propan-2-ylpyridine;1-methyl-3-propan-2-yl-1,6-naphthyridin-2-one;6-methyl-3-propan-2-yl-4-(trifluoromethyl)pyridazine;4-methyl-2-propan-2-yl-3-(trifluoromethyl)pyridine;4-propan-2-yl-1,3-benzothiazole;3-propan-2-yl-4-(trifluoromethyl)isoquinoline;2-propan-2-yl-3-(trifluoromethyl)pyrazine
1-cyclopropyloxy-4,5-difluoro-2-propan-2-ylbenzene;5-fluoro-3-methoxy-2-propan-2-ylpyridine;1-methyl-3-propan-2-yl-1,6-naphthyridin-2-one;6-methyl-3-propan-2-yl-4-(trifluoromethyl)pyridazine;4-methyl-2-propan-2-yl-3-(trifluoromethyl)pyridine;4-propan-2-yl-1,3-benzothiazole;3-propan-2-yl-4-(trifluoromethyl)isoquinoline;2-propan-2-yl-3-(trifluoromethyl)pyrazine (PubChem CID 158895492) has the molecular formula C83H95F15N10O3S and a molecular weight of 1597.78 g/mol. Its IUPAC name is 1-cyclopropyloxy-4,5-difluoro-2-propan-2-ylbenzene;5-fluoro-3-methoxy-2-propan-2-ylpyridine;1-methyl-3-propan-2-yl-1,6-naphthyridin-2-one;6-methyl-3-propan-2-yl-4-(trifluoromethyl)pyridazine;4-methyl-2-propan-2-yl-3-(trifluoromethyl)pyridine;4-propan-2-yl-1,3-benzothiazole;3-propan-2-yl-4-(trifluoromethyl)isoquinoline;2-propan-2-yl-3-(trifluoromethyl)pyrazine.
Molecular Properties
| Compound Name | 1-cyclopropyloxy-4,5-difluoro-2-propan-2-ylbenzene;5-fluoro-3-methoxy-2-propan-2-ylpyridine;1-methyl-3-propan-2-yl-1,6-naphthyridin-2-one;6-methyl-3-propan-2-yl-4-(trifluoromethyl)pyridazine;4-methyl-2-propan-2-yl-3-(trifluoromethyl)pyridine;4-propan-2-yl-1,3-benzothiazole;3-propan-2-yl-4-(trifluoromethyl)isoquinoline;2-propan-2-yl-3-(trifluoromethyl)pyrazine |
|---|---|
| PubChem CID | 158895492 |
| Molecular Formula | C83H95F15N10O3S |
| Molecular Weight | 1597.78 g/mol |
| Exact Mass | 1596.71 |
| IUPAC Name | 1-cyclopropyloxy-4,5-difluoro-2-propan-2-ylbenzene;5-fluoro-3-methoxy-2-propan-2-ylpyridine;1-methyl-3-propan-2-yl-1,6-naphthyridin-2-one;6-methyl-3-propan-2-yl-4-(trifluoromethyl)pyridazine;4-methyl-2-propan-2-yl-3-(trifluoromethyl)pyridine;4-propan-2-yl-1,3-benzothiazole;3-propan-2-yl-4-(trifluoromethyl)isoquinoline;2-propan-2-yl-3-(trifluoromethyl)pyrazine |
| SMILES | CC(C)c1cc(F)c(F)cc1OC1CC1.CC(C)c1cc2cnccc2n(C)c1=O.CC(C)c1cccc2scnc12.CC(C)c1ncc2ccccc2c1C(F)(F)F.CC(C)c1nccnc1C(F)(F)F.COc1cc(F)cnc1C(C)C.Cc1cc(C(F)(F)F)c(C(C)C)nn1.Cc1ccnc(C(C)C)c1C(F)(F)F |
| InChI | InChI=1S/C13H12F3N.C12H14F2O.C12H14N2O.C10H12F3N.C10H11NS.C9H11F3N2.C9H12FNO.C8H9F3N2/c1-8(2)12-11(13(14,15)16)10-6-4-3-5-9(10)7-17-12;1-7(2)9-5-10(13)11(14)6-12(9)15-8-3-4-8;1-8(2)10-6-9-7-13-5-4-11(9)14(3)12(10)15;1-6(2)9-8(10(11,12)13)7(3)4-5-14-9;1-7(2)8-4-3-5-9-10(8)11-6-12-9;1-5(2)8-7(9(10,11)12)4-6(3)13-14-8;1-6(2)9-8(12-3)4-7(10)5-11-9;1-5(2)6-7(8(9,10)11)13-4-3-12-6/h3-8H,1-2H3;5-8H,3-4H2,1-2H3;4-8H,1-3H3;4-6H,1-3H3;3-7H,1-2H3;4-5H,1-3H3;4-6H,1-3H3;3-5H,1-2H3 |
| InChIKey | JETXZOMFNUNORA-UHFFFAOYSA-N |
| XLogP | 24.91 |
| TPSA | 156.47 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 112 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1597.78 |
| LogP ≤ 5 | 24.91 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 14 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158895492 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.